Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma
Authors:
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 493 (1) , 800-806
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Recent advances in hepatocellular carcinoma therapyPharmacology & Therapeutics, 2017
- Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewWorld Journal of Gastroenterology, 2016
- Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targetsWorld Journal of Gastroenterology, 2016
- Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisWorld Journal of Gastroenterology, 2016
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosisHepatology International, 2015
- Immunological landscape and immunotherapy of hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2015
- Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-AnalysisJournal of Gastrointestinal Surgery, 2015
- Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future TherapiesBioMed Research International, 2014
- Hepatocellular nodules in liver cirrhosis: MR evaluationAbdominal Radiology, 2011
- Molecular mechanisms of hepatocellular carcinomaHepatology, 2008